Skip to main content

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    To Inform or Not to Inform? That Is the Question for Genetics Researchers

    Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease. But do the participants have to know?A group of 35 Parkinson…
    Learn more

  • Default content image

    First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development

    NEW YORK and  VIENNA, Austria - AFFiRiS AG announced today at a press conference in New York results of AFF008, a Phase I clinical trial of PD01A, a vaccine against Parkinson's disease. PD01A is…
    Learn more

  • Default content image

    RaceTrac Reaches $1 Million Milestone in Giving to The Michael J. Fox Foundation for Parkinson's Research

    Atlanta, GA - July 28, 2014 -RaceTrac announced that its cumulative giving to The Michael J. Fox Foundation for Parkinson's Research has exceeded $1 million. This milestone is due in large part to…
    Learn more

  • Default content image

    Parkinson's Organizations Unite to Serve Patients and Families Through National "Partners in Parkinson's" Initiative

    NEW YORK, NY, July 22, 2014 - National Parkinson's organizations are working together to help provide Parkinson's patients and caregivers with knowledge and support to optimize their care through the…
    Learn more

  • Default content image

    Leading Foundations Publish Recommendations to Accelerate Drug Repurposing for Neurodegenerative Diseases

    A new peer-reviewed publication from the Alzheimer's Drug Discovery Foundation (ADDF) and The Michael J. Fox Foundation for Parkinson's Research (MJFF) offers strategic insight on how philanthropy,…
    Learn more

  • Default content image

    The Michael J. Fox Foundation and AbbVie Launch "Partners in Parkinson's"

    NEW YORK, NY, May 27, 2014 -The Michael J. Fox Foundation (MJFF) and AbbVie announced the launch of Partners in Parkinson's, a new strategic health initiative offering comprehensive support to help…
    Learn more

  • Default content image

    Toxic Species of Parkinson's Protein Named Focus of Funding Program

    The Michael J. Fox Foundation for Parkinson's Research (MJFF) is launching a new funding program to promote collaborative analysis of subtypes of the protein alpha-synuclein. Aggregating in the…
    Learn more

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.